RhumbLine Advisers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
1,441
+55
| +4% | +$9.49K | ﹤0.01% | 3107 |
|
|
2025
Q1 | $216K | Sell |
1,386
-74
| -5% | -$11.5K | ﹤0.01% | 3069 |
|
|
2024
Q4 | $201K | Sell |
1,460
-108
| -7% | -$14.9K | ﹤0.01% | 3198 |
|
|
2024
Q3 | $234K | Buy |
1,568
+35
| +2% | +$5.23K | ﹤0.01% | 3157 |
|
|
2024
Q2 | $209K | Buy |
1,533
+143
| +10% | +$19.5K | ﹤0.01% | 3202 |
|
|
2024
Q1 | $210K | Buy |
1,390
+100
| +8% | +$15.1K | ﹤0.01% | 3151 |
|
|
2023
Q4 | $162K | Buy |
1,290
+22
| +2% | +$2.77K | ﹤0.01% | 3281 |
|
|
2023
Q3 | $119K | Buy |
1,268
+10
| +0.8% | +$936 | ﹤0.01% | 3401 |
|
|
2023
Q2 | $112K | Buy |
+1,258
| New | +$112K | ﹤0.01% | 3479 |
|